GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (XBRU:ONWD) » Definitions » Research & Development

Onward Medical NV (XBRU:ONWD) Research & Development : €13.84 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Onward Medical NV Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Onward Medical NV's Research & Development for the six months ended in Dec. 2023 was €6.20 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was €13.84 Mil.

Onward Medical NV Research & Development Historical Data

The historical data trend for Onward Medical NV's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Onward Medical NV Research & Development Chart

Onward Medical NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 5.36 5.82 7.93 13.14 13.84

Onward Medical NV Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.08 6.22 6.92 7.64 6.20

Onward Medical NV Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €13.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onward Medical NV  (XBRU:ONWD) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Onward Medical NV Research & Development Related Terms

Thank you for viewing the detailed overview of Onward Medical NV's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Onward Medical NV (XBRU:ONWD) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (XBRU:ONWD) » Definitions » Research & Development
Comparable Companies
XBRU:ALIMG XBRU:CYAD XBRU:BIOS XBRU:OXUR XBRU:HYL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX SZSE:300122 BGNE ALNY OCSE:GMAB BMRN
Traded in Other Exchanges
ONWRF:USA 63E:Germany
Address
High Tech Campus 32, Noord-Braban, Eindhoven, NH, NLD, NL-5656 AE
Website
https://www.onwd.com
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injury. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United states and four European markets: Germany, France, the UK and the Netherlands to create a customer base.

Onward Medical NV (XBRU:ONWD) Headlines

No Headlines